Resting membrane potential

723,499views

Resting membrane potential

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Flashcards

Resting membrane potential

0 of 7 complete

Transcript

Watch video only

Content Reviewers

Each cell in the human body is wrapped in a membrane that separates the inner environment and outer environment, and positively and negatively charged ions aren’t equally distributed on both sides of the membrane.

Fundamentally, it’s these differences in concentration and charge as well as permeability across the membrane that establishes the cell’s resting membrane potential.

Generally speaking there is a higher concentration of Na+ or sodium, Cl- or chloride, and Ca2+ or calcium on the outside of a cell, and a higher concentration of (K+) or potassium and (A-), which is just what we just write for negatively charged anions, on the inside of a cell.

These anions include a variety of amino acids and proteins that are produced by the cell.

Let’s start with the sodium-potassium pump which uses ATP to move three sodium ions out of the cell for every 2 potassium ions that it moves into the cell, this is the workhorse of the cell and it helps establish the concentration gradient for potassium and sodium.

Let’s focus on potassium, which has a concentration of 150 mMol/L on the inside of the cell and about 5 mMol/L on the outside of the cell.

With so much potassium within the cell relative to outside the cell, there will be fairly strong concentration gradient moving potassium ions out of the cell.

Although these ions can’t simply diffuse through the phospholipid bilayer membrane, it turns out that potassium can get across the membrane using potassium leak channels and inward rectifier channels that are scattered throughout the membrane.

So using those channels, the concentration gradient pushes potassium out of the cell, and that potassium brings with it some positive charge and leaves behind unpaired anions which carry negative charge because they aren’t able to go through the leak channels.

Over time as more potassium ions leave the cell, a negative charge builds up within the cell and this starts to attract positively charged potassium ions back into the cell, and this is called the electrostatic gradient.

This electrostatic gradient is established with the movement of relatively few ions, so it doesn’t upset the overall concentration gradient that was already established.

For potassium, the exact point when the potassium moving out of the cell due to the concentration gradient equals the potassium moving back into the cell due to the electrostatic gradient is called the equilibrium potential or nernst potential for potassium, and it’s about -92 mV.

In other words, -92 mV is the electric potential for attracting potassium into the cell that is needed to balance the concentration gradient that is pushing potassium out of the cell.

So the equilibrium potential of an ion is dependent on two things: the concentration gradient for the ion and the cell being permeable to that ion.

If we’re only dealing with a single ion, then the equilibrium potential for the ion equals the resting membrane potential for the cell.

Key Takeaways

The resting membrane potential (RMP) is the electrical potential difference across the plasma membrane of a cell when the cell is at rest and not undergoing any significant electrical activity. This potential difference is created by the unequal distribution of ions across the membrane, with positively charged ions (such as sodium and calcium) being more concentrated outside the cell and negatively charged ions (such as chloride and potassium) being more concentrated inside the cell.

Each ion has its own equilibrium potential, which is determined by the Nernst equation. It states that an ion's resting membrane potential (Vm) equals 61.5 times the log of the concentration of the ion outside the cell, divided by the concentration of the ion inside the cell, for an ion with a single charge like sodium, and Vm equals 30.75 times the log the concentration of the ion outside divided by the concentration of the ion inside for an ion with a double charge like calcium.

Vm = 61.5Log [ION]out[ION]in for single charged ions (E.g. Na+) Vm = 30.75Log [ION]out[ION]in for double charged ions (E.g. Ca2+) The cell's resting membrane potential will therefore be the summation of each individual ion's equilibrium potential.